Crossmark

“The unbearable lightness” of the primary end point in clinical trials

Crossref DOI link: https://doi.org/10.1007/s11010-024-05098-7

Published Online: 2024-08-30

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marian, A. J. https://orcid.org/0000-0002-1252-7120
License Information

Text and Data Mining valid from 2024-08-30

Version of Record valid from 2024-08-30
More Information

Article History

Received: 23 July 2024

Accepted: 18 August 2024

First Online: 30 August 2024

Declarations

:

: The author declares that there is no conflict of interest.